Here's Why DBV Technologies Shares Jumped Higher Today
Long-term data suggests longer treatments with Viaskin Peanut improve peanut tolerance.
DBV Technologies
DBVT
DBVT
$10.92
-$0.17
-1.5%
BATS BZX Real Time Price as of January 27, 2020, 4:30 p.m. EST
View Interactive DBVT Charts
DBV Technologies S.A.
News & Analysis: DBV Technologies
Why DBV Technologies Shares Soared Today
Traders cheered after the company announced the pricing details of a stock offering.
Why Conagra Brands, DBV Technologies, and Carnival Slumped Today
Find out why these stocks stood out on a down day for the market.
Why DBV Technologies Is Being Obliterated Today
Shares collapse after the company provides investors with an unfavorable regulatory update.
Why DBV Technologies Jumped Higher Today
The FDA is "supporting" the biotech submitting a marketing application for Viaskin Peanut, but how strong that support is remains to be seen.
Why DBV Technologies SA Plummeted and Aimmune Therapeutics Inc Skyrocketed Today
One biotech's phase 3 failure benefits its competitor.
Why Shares in DBV Technologies SA Are Soaring 10% Today
DBV Technologies is raising more than $244 million to develop therapies for peanut and milk allergies.
